Alzheimer's disease drug trial starts by region

3 regions, 2020 to 2025

78 Global, 2025

Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 6 to 269. Latest values: Global 78 (2025); United States 34 (2025); China 16 (2025). 0 50 100 150 200 250 300 2020 2021 2022 2023 2024 2025 Global United States China
Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 6 to 269. Latest values: Global 78 (2025); United States 34 (2025); China 16 (2025). 0 100 200 300 2020 2021 2022 2023 2024 2025 Global United States China
Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 6 to 269. Latest values: Global 78 (2025); United States 34 (2025); China 16 (2025). 0 100 200 300 2020 2021 2022 2023 2024 2025 Global United States China
View the underlying data
Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025
Region Period Type Value
Global 2025 Actual 78
Global 2024 Actual 71
Global 1 Jan 2023 to 27 Sep 2026 Actual 269
Global 2022 Actual 81
Global 2021 Actual 87
Global 2020 Actual 66
United States 2025 Actual 34
United States 2024 Actual 38
United States 2023 Actual 30
United States 2022 Actual 50
United States 2021 Actual 56
United States 2020 Actual 37
China 2025 Actual 16
China 2024 Actual 14
China 1 Jan 2023 to 27 Sep 2026 Actual 46
China 2022 Actual 11
China 2021 Actual 12
China 2020 Actual 6
Chart: StatOrigin · Source: ClinicalTrials.gov · statorigin.org CC BY 4.0